Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiplatelet”

716 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 716 results

Not applicableStudy completedNCT01843361
What this trial is testing

Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study

Who this might be right for
Ischemic Stroke
Ruhr University of Bochum 159
Post-approval studies (Phase 4)Study completedNCT01642238
What this trial is testing

Antithrombotic Effects of Ticagrelor Versus Clopidogrel

Who this might be right for
Acute Coronary Syndrome
Juan J Badimon 15
Not applicableStudy completedNCT01278043
What this trial is testing

Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention (ARIVE-PCI) Registry

Who this might be right for
Coronary Artery Disease
University of Chicago 101
Not applicableUnknownNCT05911659
What this trial is testing

Individualized and Combined Effects of Diabetes and Smoking on the Antiplatelet Activity of Ticagrelor in Acute Myocardial Infarction Patients Undergoing Primary PCI

Who this might be right for
Individualized and Combined Effects of Smoking and Diabetes on the Antiplatelet Activity in Patients Undergoing Primary Percutaneous Coronary Intervention
Mina Wageh Mohareb 60
Not applicableStudy completedNCT06876727
What this trial is testing

Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair

Who this might be right for
Abdominal Aortic Aneurysms (AAA)Endovascular Aneurysm Repair (EVAR)
Samsung Medical Center 8,325
Large-scale testing (Phase 3)Study completedNCT02506140
What this trial is testing

Platelet Reactivity in Acute Non-disabling Cerebrovascular Events

Who this might be right for
StrokeIschemic Attack, Transient
Beijing Tiantan Hospital 675
Large-scale testing (Phase 3)Study completedNCT04522102
What this trial is testing

Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral HaemorrhaGe (ASPIRING)-Pilot Phase

Who this might be right for
Intracerebral Hemorrhage
The George Institute for Global Health, China 80
Not applicableActive Not RecruitingNCT07597239
What this trial is testing

Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization

Who this might be right for
ThrombosisArterial Occlusive DiseasesThromboelastography (TEG)+4 more
Massachusetts General Hospital 130
Post-approval studies (Phase 4)UnknownNCT02030054
What this trial is testing

Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa)

Who this might be right for
Coronary Artery Disease
University of Roma La Sapienza 150
Post-approval studies (Phase 4)Active Not RecruitingNCT03947229
What this trial is testing

Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Who this might be right for
Coronary Artery DiseaseDES
Yonsei University 3,200
Post-approval studies (Phase 4)Study completedNCT03718429
What this trial is testing

Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies

Who this might be right for
Coronary Artery DiseasePeripheral Arterial DiseaseAtrial Fibrillation
University of Florida 86
Post-approval studies (Phase 4)UnknownNCT02933788
What this trial is testing

Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients

Who this might be right for
Type 2 Diabetes Mellitus
Kangbuk Samsung Hospital 116
Not applicableStudy completedNCT04481997
What this trial is testing

Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI

Who this might be right for
Type2 Diabetes MellitusCoronary Heart Disease
Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA 1,000
Not applicableStudy completedNCT03197298
What this trial is testing

Change of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromePercutaneous Coronary InterventionDrug-Eluting Stents
Thorax Centrum Twente 2,062
Not applicableEnded earlyNCT00995514
What this trial is testing

Genotype Guided Comparison of Clopidogrel and Prasugrel Outcomes Study

Who this might be right for
Cardiovascular Disease
Medco Health Solutions, Inc. 4,471
Not applicableLooking for participantsNCT05566301
What this trial is testing

Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)

Who this might be right for
Clopidogrel, Poor Metabolism ofCarotid Stenosis
IRCCS Policlinico S. Donato 1,140
Post-approval studies (Phase 4)UnknownNCT03908593
What this trial is testing

Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG

Who this might be right for
Gastrointestinal Ulcer (Peptic) or ErosionAnti-Platelet TherapyCoronary Artery Bypass
Ruijin Hospital 232
Large-scale testing (Phase 3)Looking for participantsNCT05997693
What this trial is testing

One-Month DAPT in CABG Patients

Who this might be right for
Chronic Coronary Disease
Weill Medical College of Cornell University 700
Large-scale testing (Phase 3)Looking for participantsNCT06653348
What this trial is testing

Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

Who this might be right for
Ischemic StrokeTransient Ischemic Attack
Mazandaran University of Medical Sciences 100
Not applicableEnded earlyNCT03247972
What this trial is testing

Antiplatelet Effects of Evolocumab in Patients With Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
Inova Health Care Services 30
Load More Results